Quotient Sciences, a CDMO that specializes in “niche and smaller volume” drugs, has extended a deal with Ipsen to manufacture Sohonos (palovarotene) capsules. Sohonos is currently the only medication approved by the FDA to treat the ultra-rare disease fibrodysplasia ossificans progressiva.
CDMO Quotient extends Ipsen supply pact for rare disease drug Sohonos
Latest from Blog
Partners in Nutrition will pay state $18.5M to settle food aid fraud claims
Partners in Nutrition reached a settlement to pay the state $18.5 million on the same day the state Attorney General’s Office filed a lawsuit alleging the nonprofit engaged in fraud at multiple
Hexagon Nutrition Appoints N. L. Bhatia & Associates as Secretarial Auditor for Five-Year Term
Tipranks Press Release. Post Views: 5
McCarty Family Farms opens interactive dairy nutrition exhibit
New Kansas and Ohio learning experiences show visitors how animal nutrition, science and innovation support healthy cows, dairy farms and milk quality. Post Views: 3
Score up to 40% off Optimum Nutrition, Orgain Organic, Premier Protein, more
Right now, Amazon is offering up to 40% off a selection of top protein brands, with savings on Optimum Nutrition,… Post Views: 6
Wichita Falls Area Food Bank names new Nutritional Education Manager
The Wichita Falls Area Food Bank has named its new Nutrition Education Manager. Post Views: 4